Michael K Jackson insider trades: Poniard Pharmaceuticals (PARD) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 27, 2012 | PARD | ↓ Sell | 257 | $0.83 | $214 | Direct | Mar 27, 2012 (0d) |
| Feb 16, 2012 | PARD | ↓ Sell | 2,401 | $0.87 | $2K | Direct | Feb 17, 2012 (1d) |
| Apr 13, 2011 | PARD | ↓ Sell | 7,655 | $0.37 | $3K | Direct | Apr 14, 2011 (1d) |
| Jan 5, 2011 | PARD | ↓ Sell | 44,816 | $0.52 | $23K | Direct | Jan 7, 2011 (2d) |
| Feb 8, 2010 | PARD | ↓ Sell | 3,669 | $1.62 | $6K | Direct | Feb 9, 2010 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Michael K Jackson's insider trades
Michael K Jackson is Interim CFO at Poniard Pharmaceuticals (PARD). Since Feb 8, 2010, Michael has reported no open-market purchases and 5 sales worth $35K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (11 filings), option exercises (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PARD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.